FDA approves oveporexton, first-in-class treatment for narcolepsy

The US Food and Drug Administration approves oveporexton for narcolepsy treatment.

Published 3j1 sourceNotableupdated 3j

≈ 16sSpeed

The fact

This drug targets a novel mechanism, different from existing therapies.

Patients may access this option as early as the first quarter of 2027.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on August 19, 2026